Cogna returns to profit, cuts leverage to 1.11x amid strong cash generation

<p>Higher education and basic segments drive growth; Kroton expands credit model while Vasta posts another strong cycle.</p>

By Brazil Stock Guide – Cogna (B3: COGN3) returned to profitability in the third quarter of 2025, supported by stronger operations in both higher and basic education and improved capital efficiency. The company posted a net profit of R$191.6 million, reversing a R$29.1 million loss from a year earlier, as net revenue rose 18.9% to R$1.52 billion and recurring EBITDA advanced 9.8% to R$422.7 million. Free cash flow reached R$300.1 million, while net leverage dropped to 1.11x, the lowest level in seven years.

Kroton gains traction with flexible credit model
The higher-education unit Kroton remained Cogna’s main growth engine, with revenue up 20.9% to R$1.14 billion. Its “Pague Fácil” financing program, which allows students to pay tuition in installments, boosted enrollment and average ticket prices but also lifted loan-loss provisions (PCLD), trimming EBITDA margin by 3.2 percentage points to R$370.5 million. Still, the company views the initiative as a key tool to build loyalty and pricing power in an increasingly competitive market dominated by digital players.

Vasta and Saber sustain momentum in basic education
In K–12, Vasta reported R$249.6 million in revenue (+13.4%) and R$23.1 million in recurring EBITDA (+25.4%), with its Annual Contract Value (ACV) for 2025 rising 14.3% to R$1.74 billion. Saber, Cogna’s school operator, grew 9.4% in revenue to R$145.8 million, with EBITDA down 8.2% to R$27.5 million. The business gained market share in Brazil’s federal textbook program (PNLD), reaching 30% of the high-school segment, up eight percentage points from last year — revenue recognition from those contracts will mostly occur in coming quarters.

Capital discipline and selective expansion
Cogna continued to strengthen its balance sheet, with net debt at R$2.6 billion and a steady deleveraging path since 2022. Recent capital moves include the acquisition of the Dourados Medical School (60 seats) for R$54.4 million and the extension of Vasta’s tender offer in the U.S. — US$5.00 per share, up to US$79.9 million — now open until December 9, following delays caused by the U.S. government shutdown.


Clear insights on Brazilian equities

Join portfolio managers and investors who get our curated analysis on Latin America’s largest economy.

Advertisement